Anti-Neoplastic Therapy Market Forecast to Reach $13.8 Billion by 2025

October 12, 2020

Anti-Neoplastic Therapy Market size is forecast to reach $13.8 billion by 2025, growing at a CAGR of 6.87% during the forecast period 2020-2025. Antineoplastic therapy refers to the therapy which acts to prevent, inhibit or halt the development of a neoplasm. Neoplasm or neoplasia is a new and abnormal growth of tissue in a part of the body, especially as a characteristic of cancer. Regardless of type, there are some common symptoms of neoplasia, for example, anemia, shortness of breath, abdominal pain, persistent fatigue and loss of appetite. Increasing investment by multinational companies in cancer research owing to increasing cancer prevalence among the population.

Key Takeaways
  • North America dominates the Anti-Neoplastic Therapy Market in 2019, owing to improved healthcare infrastructure and growing investments of key players in the Neoplastic Therapy Market.
  • Changing lifestyle among the general population, rising geriatric population and increasing the incidences of chronic diseases such as cancer is likely to aid in the growth of Anti-Neoplastic Therapy Market.
  • Detailed analysis on the Strength, Weakness and opportunities of the prominent players operating in the market will be provided in the Anti-Neoplastic Therapy Market report.
  • Technological complexities with the existing diagnostic examination of neoplasia is set to cause a slowdown in the growth of Anti-Neoplastic Therapy Market.

Request for Sample of the Report @

Geography – Segment Analysis
North America dominated the Anti-Neoplastic Therapy market in 2019, accounting for more than 45.3% of the overall market. Rising developments of the cancer treatments, government aided programs and favorable reimbursement policies is helping in the growth of anti – neoplastic therapy market in this region.
Rapidly growing geriatric population, greater availability of treatments and state funded startups in countries such as India has resulted in growth of the Anti-Neoplastic Therapy Market.
Drivers – Anti-Neoplastic Therapy Market 
  • Increasing Investment by the Key Manufacturers
  • Increasing Incidences of Cancer 
Anti-Neoplastic Therapy Industry Outlook
New mechanism product launches, company-merging & acquisitions, joint ventures and mass awareness and advertising about Anti-Neoplastic Therapy products are key strategies adopted by players in the Anti-Neoplastic Therapy market. In 2019, the Anti-Neoplastic Therapy market share is consolidated by the top ten players. Anti-Neoplastic Therapy top 10 companies are Amgen Inc., AstraZeneca PLC, Bayer AG, Johnson and Johnson, Merck and Co. Inc., Pfizer Inc., F. Hoffmann, La Roche AG, Eli Lilly and Company and Teva Pharmaceutical Industries Ltd. among others.
About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to to discuss more about our consulting services.
Article Categories:

Leave a Comment